04:31 PM EDT, 09/23/2025 (MT Newswires) -- Jack A. Khattar, Director, President, CEO, on September 22, 2025, sold 16,587 shares in Supernus Pharmaceuticals ( SUPN ) for $779,921. Following the Form 4 filing with the SEC, Khattar has control over a total of 2,128,056 common shares of the company, with 1,122,456 shares held directly and 1,005,600 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1356576/000153993725000018/xslF345X05/wk-form4_1758658919.xml